Quality care is our passion
“ CFM is providing new standards in tissue repair. ”
CFM is continuously investigating new drug compounds to ensure cutting edge therapies in trauma care at great length.
Traditional Drug Development is extremely costly and is consuming up to 15 years of development time, while the chance of failure is high.
In contrast, the chance of failure with respect to efficacy and safety of BMOV is much lower than usual. So far CFM has been able to develop its pipeline at low cost and has scheduled the remaining development program for relatively low costs and low risks.
CFM will be able to submit the registration dossier of BMOV in the first indication in only three years.
The following clinical trials have been scheduled in compliance with FDA - EMA guidelines
Apart from the scheduled clinical trials CFM is investigating new organic vanadium drug compounds to advance stability, biocompatibility, safety and efficacy.